world
Friday Jan 21 2022
By
Web Desk

Is Elon Musk's brain implant company Neuralink close to human testing?

By
Web Desk
Elon Musks brain-machine interface company Neuralink starts to run clinical trials by implanting brain chips in humans. — Reuters/ File
Elon Musk's brain-machine interface company Neuralink starts to run clinical trials by implanting brain chips in humans. — Reuters/ File 

  • Elon Musk's interface company Neuralink starts running clinical trials by implanting brain chips in humans.
  • Company begins to recruit employees and hire staff including a clinical trial director and a clinical trial coordinator.
  • Musk says that the implants will help paralysed people to connect with smart devices.


The brain-machine interface company Neuralink — run by billionaire Elon Musk — is starting to run clinical trials by implanting brain chips in the human brain.

According to RT, the company has begun to recruit employees and posted an advertisement to hire staff, including a clinical trial director and a clinical trial coordinator.

The ad states that the staff will “work closely with some of the most innovative doctors and top engineers, as well as working with Neuralink’s first clinical trial participants," adding that the director will lead to help build a team in order to develop “regulatory interactions that come with a fast-paced and ever-evolving environment.”

Last month, Musk said that he hopes to implant Neuralink brain chips by 2022 after getting the testing plan approved by the US Food and Drug Administration (FDA).

So far, the Neuralink brain chips have been implanted in pigs and monkeys. The company posted a video of a monkey playing video games with its mind.

In 2016, Musk along with his partners, founded Neuralink to connect the brain with the computer in order to overcome the power of Artificial Intelligence (AI).

The billionaire said that the implants will help the paralysed people to connect with smart devices and he claims to do so by bridging the signals between neurons.

Musk plans to implant chips in people with severe spinal injuries first like quadriplegics.

“We have a chance with Neuralink to restore full-body functionality to someone who has a spinal cord injury,” he said at the Wall Street Journal CEO Council summit.